Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis

References

• Howard A, O’Donoghue M, Feeney A, et al. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3(3):243–50.10.1128/AAC.45.12.3375-3380.2001
   PubMed Web of Science ®Google Scholar
• Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Iran Pol J Microbiol. 2011;60(2):169–74.
   PubMed Web of Science ®Google Scholar
• Metan G, Sariguzel F, Sumerkan B, van der Reijden T, Dijkshoorn L. Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infection, Genet Evol. 2013;14:92–7.10.1016/j.meegid.2012.11.003
   PubMed Web of Science ®Google Scholar
• Forster D, Daschner F. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis. 1998;17(2):73–7.10.1007/BF01682159
   PubMed Web of Science ®Google Scholar
• Jawad A, Heritage J, Snelling A, Gascoyne-Binzi D, Hawkey P. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol. 1996;34(12):2881–7.
   PubMed Web of Science ®Google Scholar
• Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases. Elsevier Health Sciences: Philadelphia. 2014.
   Google Scholar
• Sinha M, Srinivasa H. Mechanisms of resistance to carbapenems in meropenem-resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol. 2007;25(2):121.10.4103/0255-0857.32717
   PubMedGoogle Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–84.10.1128/AAC.01464-06
   PubMed Web of Science ®Google Scholar
• Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii a major threat worldwide. Infection Control. 2006;27(07):645–6.
   Google Scholar
• Fournier PE, Richet H, Weinstein RA. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–9.10.1086/500202
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.10.1128/CMR.00058-07
   PubMed Web of Science ®Google Scholar
• Kempf M, Rolain J-M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39(2):105–14.10.1016/j.ijantimicag.2011.10.004
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010;11(5):779–88.10.1517/14656561003596350
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–51.10.1038/nrmicro1789
   PubMed Web of Science ®Google Scholar
• Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, et al. Epidemiology of multi drug resistant uropathogenic Escherichia coli in Iran: a systematic review and meta-analysis. Japanese journal of infectious diseases. 2017;70(1):19–25.
   PubMed Web of Science ®Google Scholar
• Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents. 2011;37(2):102–9.10.1016/j.ijantimicag.2010.10.014
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infectious Diseases. 2010;23(4):332–9.10.1097/QCO.0b013e32833ae38b
   PubMed Web of Science ®Google Scholar
• Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, et al. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrobials. 2009;8(1):1.
   PubMed Web of Science ®Google Scholar
• Cambray G, Guerout A-M, Mazel D. Integrons. Annu Rev Genet. 2010;44:141–66.10.1146/annurev-genet-102209-163504
   PubMed Web of Science ®Google Scholar
• Mak JK, Kim M-J, Pham J, Tapsall J, White PA. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2009;63(1):47–54.10.1093/jac/dkn454
   PubMed Web of Science ®Google Scholar
• Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infection. 2008;14(11):1010–19.10.1111/j.1469-0691.2008.02077.x
   PubMed Web of Science ®Google Scholar
• Sedighi M, Vaez H, Moghoofeie M, Hadifar S, Oryan G, Faghri J. Molecular detection of metallo-β-lactamase gene blaVIM-1 in imipenem-resistant Pseudomonas aeruginosa strains isolated from hospitalized patients in the hospitals of Isfahan. Adv Biomed Res. 2015;4.
   PubMedGoogle Scholar
• Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis. 2010;51(1):79–84.10.1086/652975
   PubMed Web of Science ®Google Scholar
• Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011;52(6):879–91.10.3349/ymj.2011.52.6.879
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–63.
   PubMed Web of Science ®Google Scholar
• Nowak-Zaleska A, Krawczyk B, Kotlowski R, Mikucka A, Gospodarek E. Amplification of a single-locus variable-number direct-repeats with restriction fragment length polymorphism (DR-PCR/RFLP) for genetic typing of Acinetobacter baumannii strains. Polish J Microbiol. 2008;57(1):11.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Schmitt R, Wöhrmann A, Stefanik D, Seifert H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect. 2007;66(2):174–81.10.1016/j.jhin.2007.02.016
   PubMed Web of Science ®Google Scholar
• Wroblewska M, Towner K, Marcher H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infection. 2007;13(5):490–6.10.1111/j.1469-0691.2007.01694.x
   PubMed Web of Science ®Google Scholar
• Halstead DC, Abid J, Dowzicky MJ. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline evaluation and surveillance trial. J Infect. 2007;55(1):49–57.10.1016/j.jinf.2006.11.018
   PubMed Web of Science ®Google Scholar
• Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007;44(12):1577–84.10.1086/518170
   PubMed Web of Science ®Google Scholar
• Shi W-F, Jiang J-P, Xu N, Huang Z-M, Wang Y-Y. Inhibitory effects of reserpine and carbonyl cyanide m-chloro-phenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii. Chin Med J. 2005;118(4):340–3.
   PubMed Web of Science ®Google Scholar
• Srinivasan VB, Rajamohan G, Gebreyes WA. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(12):5312–6.10.1128/AAC.00748-09
   PubMed Web of Science ®Google Scholar
• Kunz AN, Brook I. Emerging resistant gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010;56(6):492–500.10.1159/000321018
   PubMed Web of Science ®Google Scholar
• Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother. 2008;52(11):3837–43.10.1128/AAC.00570-08
   PubMed Web of Science ®Google Scholar
• Pajand O, Rezaee MA, Nahaei MR, Mahdian R, Aghazadeh M, Soroush MH, et al. Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains. Burns. 2013;39(7):1414–9.10.1016/j.burns.2013.03.024
   PubMed Web of Science ®Google Scholar
• Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA, et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J Med Microbiol. 2015;64(7):767–73.10.1099/jmm.0.000090
   PubMed Web of Science ®Google Scholar
• Mirnejad R, Mostofi S, Masjedian F. Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. Asian Pacific J Tropical Biomed. 2013;3(2):140–5.10.1016/S2221-1691(13)60038-6
   PubMedGoogle Scholar
• Khalilzadegan S, Sade M, Godarzi H, Eslami G, Hallajzade M, Fallah F, et al. Beta-lactamase encoded genes bla TEM and bla CTX among Acinetobacter baumannii species isolated from medical devices of intensive care units in Tehran hospitals. Int J Antimicrob Agents.  2016;9(5):1–5.
   Google Scholar
• Davoudi A, Najafi N, Alian S, Tayebi A, Ahangarkani F, Rouhi S, et al. Resistance pattern of antibiotics in patient underwent open heart surgery with nosocomial infection in North of Iran. Global J Health Sci. 2016;8(2):288.
   Google Scholar
• Ramazanzadeh R, McNerney R. Variable number of tandem repeats (VNTR) and its application in bacterial epidemiology. Pakistan J Biol Sci: PJBS. 2007;10(16):2612–21.
   PubMedGoogle Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surgery. 2014;12(12):1495–9.10.1016/j.ijsu.2014.07.013
   PubMed Web of Science ®Google Scholar
• Moosazadeh M, Nekoei-moghadam M, Emrani Z, Amiresmaili M. Prevalence of unwanted pregnancy in Iran: a systematic review and meta-analysis. Int J Health Planning Manage. 2014;29(3):e277–90.10.1002/hpm.v29.3
   PubMed Web of Science ®Google Scholar
• Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. John Wiley & Sons; 2008.
   Google Scholar
• Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.10.1002/(ISSN)1097-0258
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community-and healthcare-associated multidrug-resistant bacteria. Adv Drug Delivery Rev. 2014;78:3–13.10.1016/j.addr.2014.08.003
   PubMed Web of Science ®Google Scholar
• Manchanda V, Sinha S, Singh N. Multidrug resistant Acinetobacter. J Global Infectious Diseases. 2010;2(3):291.10.4103/0974-777X.68538
   PubMedGoogle Scholar
• Pourhajibagher M, Hashemi FB, Pourakbari B, Aziemzadeh M, Bahador A. Antimicrobial resistance of Acinetobacter baumannii to imipenem in Iran: a systematic review and meta-analysis. Open Microbiol J. 2016;10:32.10.2174/1874285801610010032
   PubMedGoogle Scholar
• Ronat J-B, Kakol J, Khoury MN, Berthelot M, Yun O, Brown V, et al. Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit. PLoS ONE. 2014;9(8):e101017.10.1371/journal.pone.0101017
   PubMed Web of Science ®Google Scholar
• Sonnevend A, Ghazawi A, Al Munthari N, Pitout M, Hamadeh MB, Hashmey R, et al. Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals. J Med Microbiol. 2013;62(Pt_4):582–90.10.1099/jmm.0.055681-0
   PubMed Web of Science ®Google Scholar
• Al-Sweih N, Al-Hubail M, Rotimi V. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J Infection Public Health. 2012;5(1):102–8.10.1016/j.jiph.2011.11.004
   PubMedGoogle Scholar
• Begum S, Hasan F, Hussain S, Shah AA. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pakistan journal of medical sciences. 2013;29(5):1253.
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–21.10.1185/03007995.2015.1018989
   PubMed Web of Science ®Google Scholar
• Feizabadi M, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis. 2008;61(4):274–8.
   PubMed Web of Science ®Google Scholar
• Gounden R, Bamford C, van Zyl-Smit R, Cohen K, Maartens G. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infectious Diseases. 2009;9(1):1.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Bergen PJ, Bulitta JB, Tsuji B, Forrest A, Nation RL, et al. Synergistic Activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2013;57(8):3738–45.10.1128/AAC.00703-13
   PubMed Web of Science ®Google Scholar
• Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, et al. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Chemotherapy. 2014;59(5):325–9.
   Web of Science ®Google Scholar
• Wang Y, Bao W, Guo N, Chen H, Cheng W, Jin K, et al. Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures. World J Microbiol Biotechnol. 2014;30(12):3015–25.10.1007/s11274-014-1728-7
   PubMed Web of Science ®Google Scholar
• Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;45(1):8–18.10.1016/j.ijantimicag.2014.10.002
   PubMed Web of Science ®Google Scholar
• Japoni-Nejad A, Sofian M, van Belkum A, Ghaznavi-Rad E. Nosocomial outbreak of extensively and pan drug-resistant Acinetobacter baumannii in tertiary hospital in central part of Iran. Jundishapur J Microbiol. 2013;6(8).
   Web of Science ®Google Scholar
• Kamalbeik S, Kouchek M, Baseri Salehi M, Fallah F, Malekan MA, Talaie H. Prevalence of Class 2 integrons in multidrug-resistant Acinetobacter Baumannii in toxicological ICU patients in Tehran. Iranian J Toxicology. 2013;7(22):900–6.
   Google Scholar
• Mostofi S, Mirnejad R, Masjedian F. Multi-drug resistance in Acinetobacter baumannii strains isolated from clinical specimens from three hospitals in Tehran-Iran. African Journal of Microbiology Research. 2011;5(21):3579–82.
   Google Scholar
• Peymani A, Nahaei M-R, Farajnia S, Hasani A, Mirsalehian A, Sohrabi N, et al. High prevalence of metallo-b-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis. 2011;64:69–71.
   PubMed Web of Science ®Google Scholar
• Bazargani A, Hashemizadeh Z. Bacteremia due to multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL) producing Acinetobacter baumannii. African J Microbiol Res. 2011;5(21):3483–6.
   Google Scholar
• Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iranian J Microbiol. 2011;3(2):68–74.
   PubMedGoogle Scholar
• Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, et al. Prevalence of OXA-Type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microbial Drug Resistance. 2012;18(4):385–9.10.1089/mdr.2011.0077
   PubMed Web of Science ®Google Scholar
• Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, et al. Emergence of Rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel international clone variants. Microbial Drug Resistance. 2013;19(5):397–406.10.1089/mdr.2012.0233
   PubMed Web of Science ®Google Scholar
• Farahani R, Moniri R, Farahani KD. Multi-drug resistant Acinetobacter-derived cephalosporinase and OXAsetC genes in clinical specimens of Acinetobacter spp. isolated from teaching hospital. Jundishapur J Microbiol. 2013;6(2):181–5.
   Web of Science ®Google Scholar
• Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii carrying bla oxA type genes isolated from hospitalized patients. Novelty Biomed. 2013;1(2):54–61.
   Google Scholar
• Nikasa P, Abdi-Ali A, Rahmani-Badi A, Al-Hamad A. In vitro Evaluation of proton motive force-dependent efflux pumps among multidrug resistant Acinetobacter baumannii isolated from patients at Tehran Hospitals. Jundishapur J Microbiol. 2013;6(7).
   Web of Science ®Google Scholar
• Karmostaji A, Peerayeh SN, Salmanian AH. Distribution of OXA-type class D β-lactamase genes among nosocomial multi drug resistant Acinetobacter baumannii isolated in Tehran hospitals. Jundishapur J Microbiol. 2013;6(5).
   Web of Science ®Google Scholar
• Mirnejad R, Vafaei S. Antibiotic resistance patterns and the prevalence of ESBLs among strains of Acinetobacter baumannii isolated from clinical specimens. JGMI. 2013;2:1–8.
   Google Scholar
• Owlia P, Azimi L, Gholami A, Asghari B, Lari AR. ESBL-and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med. 2012;20(3):182–7.
   PubMedGoogle Scholar
• Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Peymani A, Sohrabi N. Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran. Iranian J Basic Med Sci. 2013;16(6):751–5.
   PubMed Web of Science ®Google Scholar
• Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: a study in western Iran. Iranian J Microbiol. 2013;5(3):195–202.
   PubMedGoogle Scholar
• Taherikalani M, Etemadi G, Geliani KN, Fatollahzadeh B, Soroush S, Feizabadi MM. Emergence of multi and pan-drug resistance Acinetobacter baumannii carrying blaOXA-type-carbapenemase genes among burn patients in Tehran, Iran. Saudi Med J. 2008;29(4):623–4.
   PubMed Web of Science ®Google Scholar
• Bahador A, Raoofian R, Taheri M, Pourakbari B, Hashemizadeh Z, Hashemi FB. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile. Microbial Drug Resistance. 2014;20(6):632–40.10.1089/mdr.2013.0146
   PubMed Web of Science ®Google Scholar
• Behzadnia S, Davoudi A, Rezai MS, Ahangarkani F. Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of Iran. Iranian Red Crescent Med J. 2014;16(2).
   PubMed Web of Science ®Google Scholar
• Vakili B, Khorvash F, Fazeli H, Khaleghi M. Detection of quinolone-resistance mutations of parC gene in clinical isolates of Acinetobacter baumannii in Iran. Journal Res Med Sci: Official J Isfahan University Med Sci. 2014;19(6):567.
   Google Scholar
• Vakili B, Fazeli H, Shoaei P, Yaran M, Ataei B, Khorvash F, et al. Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran. J Res Med Sci. 2014;19(3).
   Google Scholar
• Jahani-Sherafat S, Razaghi M, Rosenthal VD, Tajeddin E, Seyedjavadi S, Rashidan M, et al. Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: findings from the International Nocosomial Infection Control Consortium (INICC). J Infection Public Health. 2015;8(6):553–61.10.1016/j.jiph.2015.04.028
   PubMed Web of Science ®Google Scholar
• Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB. Genotypic and antimicrobial susceptibility of carbapenem-resistant Acinetobacter baumannii: analysis of is aba elements and blaOXA-23-like genes including a new variant. Front Microbiol. 2015;6.
   Web of Science ®Google Scholar
• Armin S, Karimi A, Fallah F, Tabatabaii SR, Alfatemi SMH, Khiabanirad P, et al. Antimicrobial resistance patterns of Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus isolated from patients with nosocomial infections admitted to tehran hospitals. Arch Pediatric Infectious Diseases. 2015;3(4).
   Web of Science ®Google Scholar
• Bahador A, Raoofian R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, et al. The prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii species of different international clone lineages among patients with burning in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7).
   Web of Science ®Google Scholar
• Anvarinejad M, Japoni A, Davarpanah MA, Mahmudi H, Mammina C, Vazin A. Phenotypic and molecular epidemiology of Acinetobacter calcoaceticus baumannii complex strains spread at nemazee hospital of Shiraz, Iran. Jundishapur J Microbiol. 2015;8(6).
   PubMed Web of Science ®Google Scholar
• Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, Emaneini M, Aligholi M, Sadeghifard N, et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children’s Medical Center of Tehran: a 6-year prospective study. Acta Med Iranica. 2010;48(3):178–84.
   PubMedGoogle Scholar
• Alaei N, Aziemzadeh M, Bahador A. Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran. J Global Antimicrob Resistance. 2016;5:75–9.10.1016/j.jgar.2015.12.005
   PubMed Web of Science ®Google Scholar
• Baygloo NS, Bouzari M, Rahimi F, Abedini F, Yadegari S, Soroushnia M, et al. Identification of genomic species of Acinetobacter Isolated from burns of ICU patients. Arch Iranian Medicine (AIM). 2015;18(10).
   Google Scholar